Literature DB >> 18789939

American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease.

Peter J Kahrilas1, Nicholas J Shaheen, Michael F Vaezi, Stephen W Hiltz, Edgar Black, Irvin M Modlin, Steve P Johnson, John Allen, Joel V Brill.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18789939     DOI： 10.1053/j.gastro.2008.08.045

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  157 in total

1.  Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.

Authors:  Marc A Ward; Christy M Dunst; Ezra N Teitelbaum; Valerie J Halpin; Kevin M Reavis; Lee L Swanström; Steven R DeMeester
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

2.  Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus.

Authors:  Patrick Yachimski; Richard M Peek
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

3.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

4.  The value of branded proton pump inhibitors: formulary considerations.

Authors:  David A Peura; Rosemary R Berardi; Javier Gonzalez; Louis Brunetti
Journal:  P T       Date:  2011-07

5.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 6.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

7.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 8.  Quality improvement in gastroenterology clinical practice.

Authors:  Rakhi Kheraj; Sumeet K Tewani; Gyanprakash Ketwaroo; Daniel A Leffler
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

9.  Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.

Authors:  David A Kleiman; Toni Beninato; Brian P Bosworth; Laurent Brunaud; Thomas Ciecierega; Carl V Crawford; Brian G Turner; Thomas J Fahey; Rasa Zarnegar
Journal:  J Gastrointest Surg       Date:  2013-11-09       Impact factor: 3.452

10.  Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial.

Authors:  Michele Caselli; Giovanni Zuliani; Francesca Cassol; Nadia Fusetti; Elena Zeni; Natalina Lo Cascio; Cecilia Soavi; Sergio Gullini
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.